NOUGUES MAXIMO F
SEC CIK 1758507 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PBYI | PUMA BIOTECHNOLOGY, INC. | CFO | 230.6K | — | $477.6K | 33 | 2021-07-02 | 2026-07-06 |
Most active insiders at PBYI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | AUERBACH ALAN H | Pres, CEO, Dir, 10% | — | $568.9K |
| 2 | Cesano Alessandra | Dir | — | $567.0K |
| 3 | Senderowicz Adrian | Dir | — | $194.3K |
| 4 | MOYES JAY M | Dir | — | $158.8K |
| 5 | NOUGUES MAXIMO F | CFO | — | $141.7K |
| 6 | WILSON TROY EDWARD | Dir | — | $123.2K |
| 7 | HUNT DOUGLAS M | See Remarks | — | $122.6K |
| 8 | MILLER MICHAEL PATRICK | Dir | — | $97.2K |
| 9 | Dorval Allison | Dir | — | $83.6K |
| 10 | Stuglik Brian M | Dir | — | $58.3K |
Transactions 33
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-08 20:18 | 2026-07-06 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $8.26 | -9,386 | 230.6K | -4% | -$77.6K |
| D | 2026-02-20 | 2026-02-18 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | A - Grant | $0.00 | +46.7K | 240.0K | +24% | $0 |
| M | 2026-01-08 | 2026-01-06+ | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $5.86 | -10.9K | 193.3K | -5% | -$64.2K |
| M | 2025-07-10 | 2025-07-08+ | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $3.53 | -9,522 | 204.2K | -4% | -$33.7K |
| D | 2025-02-11 | 2025-02-07 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | A - Grant | $0.00 | +61.5K | 213.8K | +40% | $0 |
| 2025-01-03 | 2025-01-02 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $3.15 | -10.2K | 152.3K | -6% | -$32.2K | |
| 2024-07-18 | 2024-07-17 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $3.70 | -4,156 | 162.5K | -2% | -$15.4K | |
| 2024-07-02 | 2024-07-02 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $3.27 | -5,295 | 166.7K | -3% | -$17.3K | |
| D | 2024-02-14 | 2024-02-12 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | A - Grant | $0.00 | +43.3K | 172.0K | +34% | $0 |
| 2024-01-05 | 2024-01-03 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $4.49 | -15.7K | 128.7K | -11% | -$70.4K | |
| 2023-07-06 | 2023-07-03 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $3.31 | -14.7K | 144.3K | -9% | -$48.6K | |
| D | 2023-02-14 | 2023-02-10 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | A - Grant | $0.00 | +58.6K | 159.0K | +58% | $0 |
| 2023-01-05 | 2023-01-03 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $4.18 | -10.5K | 100.4K | -9% | -$43.9K | |
| 2022-12-06 | 2022-12-02 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $4.50 | -159 | 110.9K | -0.1% | -$715.50 | |
| 2022-11-04 | 2022-11-02 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $2.25 | -163 | 111.1K | -0.1% | -$366.75 | |
| 2022-10-05 | 2022-10-03 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $2.34 | -165 | 111.2K | -0.1% | -$386.10 | |
| 2022-09-07 | 2022-09-02 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $2.59 | -164 | 111.4K | -0.1% | -$424.76 | |
| 2022-08-04 | 2022-08-02 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $2.89 | -161 | 111.6K | -0.1% | -$465.29 | |
| A | 2022-08-04 | 2022-07-05 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $2.63 | -9,328 | 111.7K | -8% | -$24.5K |
| 2022-07-07 | 2022-07-05 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $2.63 | -5,835 | 64.6K | -8% | -$15.3K | |
| 2022-06-06 | 2022-06-02 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $1.92 | -162 | 121.1K | -0.1% | -$311.04 | |
| 2022-05-04 | 2022-05-03 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $2.34 | -165 | 121.2K | -0.1% | -$386.10 | |
| 2022-04-05 | 2022-04-04 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $3.08 | -206 | 121.4K | -0.2% | -$634.48 | |
| D | 2022-03-14 | 2022-03-03 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | A - Grant | $0.00 | +62.2K | 121.6K | +105% | $0 |
| 2022-03-04 | 2022-03-02 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $2.26 | -169 | 59.4K | -0.3% | -$381.94 | |
| 2022-02-03 | 2022-02-02 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $2.48 | -199 | 59.6K | -0.3% | -$493.52 | |
| 2022-01-05 | 2022-01-03 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $3.19 | -7,484 | 59.8K | -11% | -$23.9K | |
| 2021-12-06 | 2021-12-02 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $2.95 | -162 | 67.3K | -0.2% | -$477.90 | |
| 2021-11-03 | 2021-11-02 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $5.67 | -156 | 67.4K | -0.2% | -$884.52 | |
| 2021-10-06 | 2021-10-04 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $6.20 | -161 | 67.6K | -0.2% | -$998.20 | |
| 2021-09-03 | 2021-09-02 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $7.51 | -155 | 67.8K | -0.2% | -$1,164 | |
| 2021-08-03 | 2021-08-02 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $7.54 | -154 | 67.9K | -0.2% | -$1,161 | |
| 2021-07-06 | 2021-07-02 | PBYI | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F | CFO | S - Sale | $9.26 | -155 | 68.1K | -0.2% | -$1,435 |
Purchase Sale Sale after option exercise All abbreviations